REPL
Replimune Group Inc
$11.07
0.13 (1.16%) Today
— up— down
Market Cap
$914M+19.2%
Revenue (TTM)
$0
$0Net Income (TTM)
$-283,727,034
$-283,727,034EPS (TTM)
-3.44
-3.44Shares Out
82.57M
82.57MOpen
$11.97
$11.97Previous Close
$11.20
$11.20Day Range
$10.97 – $12.49
$10.97 – $12.4952-Week Range
$1.50 – $13.24
$1.50 – $13.24Beta
0.86
0.86Volume
4.26M
4.26MAvg Volume
5.89M
5.89MAnalyst Rating
Hold
HoldExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout REPL
Related
News
Replimune: Stock Buoyant On Third Try At RP1 Approval - FDA AdCom May Be Crucial
SeekingAlpha · 17h ago
Wedbush Maintains Neutral on Replimune Group, Raises Price Target to $9
Benzinga · 18h ago
Replimune Group Q4 EPS $(0.76) Misses $(0.71) Estimate
Benzinga · 1d ago
Replimune Group Says FDA Accepts Resubmission Of BLA For RP1 In Combination With Nivolumab For Advanced Melanoma, With August 2 Goal Date And Expects Adcom Meeting In Late July
Benzinga · 4d ago